Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3499Neoplasms 2740Prostatic Neoplasms 1583Colorectal Neoplasms 1248Lung Neoplasms 1188Motor Activity 766Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 560Carcinoma, Hepatocellular 559Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 438Anxiety Disorders 401Ovarian Neoplasms 399Pain 376Esophageal Neoplasms 347Polycystic Ovary Syndrome 341Neoplasm Metastasis 340Fatigue 324Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 286Multiple Myeloma 283Endometrial Neoplasms 263Lymphoma 258Hematologic Neoplasms 251

Interventions

Probiotics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × Generalized Anxiety Disorder × Clear all
NCT03674138 2026-02-06

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
99 enrolled

Generalized Anxiety Disorder, Anxiety Disorders, Depression, Depressive Disorder, Major, Depressive Disorder, Neoplasms

NCT04784182 2023-08-24

ABBCS

Auburn University

Phase NA Terminated
3 enrolled 10 charts

Generalized Anxiety Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡